Chapter 1. TISSUE DIAGNOSTICS MARKET– Scope & Methodology

1.1. Market Segmentation

1.2. Assumptions

1.3. Research Methodology

1.4. Primary Sources

1.5. Secondary Sources

Chapter 2. TISSUE DIAGNOSTICS MARKET– Executive Summary

2.1. Market Size & Forecast – (2023 – 2030) ($M/$Bn)

2.2. Key Trends & Insights

2.3. COVID-111 Impact Analysis

      2.3.1. Impact during 2023 – 2030

      2.3.2. Impact on Supply – Demand

Chapter 3. TISSUE DIAGNOSTICS MARKET– Competition Scenario

3.1. Market Share Analysis

3.2. Product Benchmarking

3.3. Competitive Strategy & Development Scenario

3.4. Competitive Pricing Analysis

3.5. Supplier - Distributor Analysis

Chapter 4. TISSUE DIAGNOSTICS MARKET- Entry Scenario

4.1. Case Studies – Start-up/Thriving Companies

4.2. Regulatory Scenario - By Region

4.3 Customer Analysis

4.4. Porter's Five Force Model

       4.4.1. Bargaining Power of Suppliers

       4.4.2. Bargaining Powers of Customers

       4.4.3. Threat of New Entrants

       4.4.4. Rivalry among Existing Players

       4.4.5. Threat of Substitutes

Chapter 5. TISSUE DIAGNOSTICS MARKET- Landscape

5.1. Value Chain Analysis – Key Stakeholders Impact Analysis

5.2. Market Drivers

5.3. Market Restraints/Challenges

5.4. Market Opportunities

Chapter 6. TISSUE DIAGNOSTICS MARKET– By Product  

6.1. Instruments

6.2. Consumables

Chapter 7. TISSUE DIAGNOSTICS MARKET– By Technology

7.1. Immunohistochemistry

7.2. In Situ Hybridization

7.3. Digital Pathology and Workflow Management

7.4. Special Staining

Chapter 8. TISSUE DIAGNOSTICS MARKET– By Disease

8.1. Breast Cancer

8.2. Gastric Cancer

8.3. Lymphoma

8.4. Prostate Cancer

8.5. Non-Small Cell Lung Cancer

8.6. Others

Chapter 9. TISSUE DIAGNOSTICS MARKET– By End-User

9.1. Hospitals

9.2. Research Laboratories

9.3. Pharmaceutical Companies

9.4. Contract Research Organizations

9.5. Others

Chapter 10. TISSUE DIAGNOSTICS MARKET– By Region

10.1. North America

10.2. Europe

10.3. The Asia Pacific

10.4. Latin America

10.5. Middle-East and Africa

Chapter 11. TISSUE DIAGNOSTICS MARKET – Company Profiles – (Overview, Product Portfolio, Financials, Developments)

11.1. Company 1

11.2. Company 2

11.3. Company 3

11.4. Company 4

11.5. Company 5

11.6. Company 6

11.7. Company 7

11.8. Company 8

11.9. Company 9

11.10. Company 10